drugset / Trial / NCT00385021

ChronoFOLFOX Plus Avastin for Patients With Metastatic Colorectal Cancer

NCT00385021 ↗

Phase 2 Terminated 20 enrolled Southwestern Regional Medical Center
Non-randomizedSingle-groupOpen-labelTreatment

Summary

To determine efficacy in the delivery of chronomodulated chemotherapy.

Timeline

Start
2006-10
Primary completion
—
Completion
2007-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Bevacizumab Monoclonal antibody — —
Subject Leucovorin Small molecule — —
Subject Oxaliplatin Small molecule — —
Subject fluorouracil Small molecule — —

Indications